Atherosclerosis
Volume 192, Issue 2 , Pages 235-242 , June 2007

Screening patients for subclinical atherosclerosis with non-contrast cardiac CT

  • Reza Ardehali

      Affiliations

    • Stanford Hospital, Division of Cardiovascular Medicine, Stanford, CA, United States
    • Corresponding Author InformationCorresponding author at: Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, H-2157 Stanford, CA 94305-5233, United States. Tel.: +1 650 723 8138; fax: +1 650 724 4034.
    • ,
  • Khurram Nasir

      Affiliations

    • Massachusetts General Hospital Cardiac MRI, PET, CT Program, Boston, MA, United States
    • ,
  • Aravindan Kolandaivelu

      Affiliations

    • Johns Hopkins Ciccarone Preventive Cardiology Center, Baltimore, MD, United States
    • ,
  • Matthew J. Budoff

      Affiliations

    • UCLA Division of Cardiology, Torrance, CA, United States
    • ,
  • Roger S. Blumenthal

      Affiliations

    • Johns Hopkins Ciccarone Preventive Cardiology Center, Baltimore, MD, United States

Received 15 June 2006 ,Revised 16 January 2007 ,Accepted 16 March 2007.

References 

  1. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the early detection of cancer, 2005. CA Cancer J Clin. 2005;55:31–44
  2. Kannel WB, D’Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004;14:16–26
  3. Shaw LJ, Blumenthal RS, Raggi P. Screening asymptomatic low-risk individuals for coronary heart disease: issues and controversies. J Nucl Cardiol. 2004;11:382–387
  4. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–484
  5. Desai MY, Nasir K, Braunstein JB, et al. Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individuals. Am Heart J. 2004;148:871–877
  6. Kullo IJ, Ballantyne CM. Conditional risk factors for atherosclerosis. Mayo Clin Proc. 2005;80:219–230
  7. Lee TH, Boucher CA. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med. 2001;344:1840–1845
  8. Greenland P, Gaziano JM. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med. 2003;349:465–473
  9. Stary HC, Chandler RE, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. American Heart Association. Circulation. 2005;92:1355–1374
  10. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56–62
  11. Patel SN, Rajaram V, Pandya S, et al. Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004;6:60–68
  12. Hoffmann MH, Shi H, Schmitz BL, et al. Noninvasive coronary angiography with multislice computed tomography. JAMA. 2005;293:2471–2478
  13. Mollet NR, Cademartiri F, de Feyter PJ. Non-invasive multislice CT coronary imaging. Heart. 2005;9:401–407
  14. Greenland P, Kizilbash MA. Coronary computed tomography in coronary risk assessment. J Cardiopulm Rehabil. 2005;25:3–10
  15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
  16. Akosah KO, Shaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?. J Am Coll Cardiol. 2003;41:1475–1479
  17. Michos ED, Nasir K, Braunstein JB, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis. 2006;184:201–206
  18. Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations?. Circulation. 2002;105:886–892
  19. Fathi R, Marwick TH. Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J. 2001;141:694–703
  20. Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16–E22
  21. O’Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000;102:126–140
  22. Budoff MJ, Achenbach S, Blumenthal RS, et al. American Heart Association Committee on Cardiovascular Imaging and Intervention; American Heart Association Council on Cardiovascular Radiology and Intervention; American Heart Association Committee on Cardiac Imaging, Council on Clinical Cardiology. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–1791
  23. Mieres JH, Shaw LJ, Arai A, et al. Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682–696
  24. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601–1610
  25. O’Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol. 2000;85:945–948
  26. Nallamothu BK, Saint S, Bielak LF, et al. Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. Arch Intern Med. 2001;161:833–838
  27. Hoff JA, Daviglus ML, Chomka EV, Krainik AJ, Sevrukov A, Kondos GT. Conventional coronary artery disease risk factors and coronary artery calcium detected by electron beam tomography in 30,908 healthy individuals. Ann Epidemiol. 2003;13:163–169
  28. Taylor AJ, Arora NS, Feuerstein I, et al. Relation between coronary artery calcium and incident chest pain in a community-dwelling screening population. Am J Cardiol. 2005;96:61–63
  29. Qiao JH, Doherty TM, Fishbein MC, et al. Calcification of the coronary arteries in the absence of atherosclerotic plaque. Mayo Clin Proc. 2005;80:807–809
  30. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998;31:126–133
  31. Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J. 2001;141:375–382
  32. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826–833
  33. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol. 2002;39:225–230
  34. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation. 1999;99:2633–2638
  35. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology. 2005;234:35–43
  36. Schmermund A, Mohlenkamp S, Berenbein S, et al. Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis. 2006;185:177–182
  37. Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006;27:713–721
  38. Lamonte MJ, fitzGerald SJ, Church TS, et al. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol. 2005;162:421–429
  39. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O’Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors. Mean three-years outcomes in the Prospective Army Coronary Calcium (PACC) Project. J Am Coll Cardiol. 2005;46:807–814
  40. Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112:572–577
  41. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol. 2005;46:158–165
  42. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–215
  43. Shemesh J, Morag-Koren N, Goldbourt U, et al. Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens. 2004;22:605–610
  44. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003;107:2571–2576
  45. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol. 2000;86:495–498
  46. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253–1260
  47. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313–1320
  48. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of Asymptomatic Adults with Elevated Coronary Calcium Scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study Randomized Clinical Trial. J Am Coll Cardiol. 2005;46:166–172
  49. Sever PS, Dahlöf B, Poulter N, et al. Östergren J for the ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149–1158
  50. Rumberger JA. Cost effectiveness of coronary calcification scanning using electron beam tomography in intermediate and high risk asymptomatic individuals. J Cardiovasc Risk. 2000;7:113–119
  51. Schragin JG, Weissfeld JL, Edmundowicz D, Strollo DC, Fuhrman CR. Non-cardiac findings on coronary electron beam computed tomography scanning. J Thorac Imaging. 2004;19:82–86
  52. Detrano RC, Anderson M, Nelson J, et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility—MESA study. Radiology. 2005;236:477–484
  53. Rumberger JA. Tomographic plaque imaging with CT: technical considerations and capabilities. Prog Cardiovasc Dis. 2003;46:123–134
  54. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394–399

PII: S0021-9150(07)00189-X

doi: 10.1016/j.atherosclerosis.2007.03.022

Atherosclerosis
Volume 192, Issue 2 , Pages 235-242 , June 2007

Article Tools